Core Viewpoint - The financial performance and trading activity of Shengjian Medical indicate a mixed sentiment among investors, with notable fluctuations in financing and stockholder dynamics [1][2][3]. Group 1: Financial Performance - Shengjian Medical reported a revenue of 7.897 billion yuan for the period from January to September 2025, reflecting a year-on-year growth of 30.10% [2]. - The company's net profit attributable to shareholders reached 732 million yuan, marking a year-on-year increase of 32.36% [2]. - Cumulatively, the company has distributed 2.875 billion yuan in dividends since its A-share listing, with 1.729 billion yuan paid out in the last three years [3]. Group 2: Trading Activity - On January 28, Shengjian Medical's stock price fell by 1.41%, with a trading volume of 164 million yuan [1]. - The financing buy-in amount for the day was 16.99 million yuan, while the financing repayment was 18.75 million yuan, resulting in a net financing outflow of 1.76 million yuan [1]. - As of January 28, the total balance of margin trading for Shengjian Medical was 380 million yuan, with the financing balance accounting for 1.78% of the circulating market value, indicating a high level compared to the past year [1]. Group 3: Shareholder Dynamics - As of September 30, 2025, the number of shareholders for Shengjian Medical increased to 32,100, up by 15.06% from the previous period [2]. - The average number of circulating shares per shareholder rose to 18,048 shares, an increase of 186.92% compared to the last period [2]. - Among the top ten circulating shareholders, notable changes include a decrease in holdings by Huabao Zhongzheng Medical ETF and a slight increase by Hong Kong Central Clearing Limited [3].

Group 1 - The core point of the news is that Steady Medical has experienced a decline in stock price, dropping 5.07% to 36.15 CNY per share, with a total market value of 21.051 billion CNY [1] - Steady Medical's stock has fallen for three consecutive days, with a cumulative decline of 4.15% during this period [1] - The company, established on August 24, 2000, specializes in the research, production, and sales of cotton products, with its main revenue sources including wet and dry cotton towels (19.87%), surgical consumables (18.15%), traditional wound care products (13.88%), and sanitary napkins (13.02%) [1] Group 2 - From the perspective of fund holdings, one fund under Fuan Da has Steady Medical as a top ten holding, with 12,500 shares held, representing 0.97% of the fund's net value [2] - The fund, Fuan Da Steady Allocation 6-Month Holding Period Mixed Fund (015047), has reported a year-to-date return of 0.57% and a one-year return of 7.06% [2] - The fund manager, Zhao Hengyi, has a tenure of over 14 years, with the best fund return during his management being 44.66% [2]

Core Viewpoint - The stock of Wanjian Medical has experienced fluctuations, with a recent decline of 2.03%, and the company shows a mixed performance in terms of stock price changes over different time frames [1]. Company Overview - Wanjian Medical, established on August 24, 2000, and listed on September 17, 2020, is located in Longhua District, Shenzhen, Guangdong Province. The company specializes in the research, production, and sales of cotton products [1]. - The main revenue sources for Wanjian Medical include: - Consumer products - wet and dry cotton towels (19.87%) - Medical consumables - operating room consumables (18.15%) - Medical consumables - traditional wound care and dressing products (13.88%) - Consumer products - sanitary napkins (13.02%) - Consumer products - adult apparel (12.73%) - Consumer products - infant and children's apparel and supplies (11.36%) - Other spun products (5.24%) - Other non-woven products (4.88%) - Other (supplementary) (0.87%) [1]. Financial Performance - For the period from January to September 2025, Wanjian Medical achieved a revenue of 7.897 billion yuan, reflecting a year-on-year growth of 30.10%. The net profit attributable to the parent company was 732 million yuan, with a year-on-year increase of 32.36% [2]. - Since its A-share listing, Wanjian Medical has distributed a total of 2.875 billion yuan in dividends, with 1.729 billion yuan distributed over the past three years [3]. Shareholder Information - As of September 30, 2025, Wanjian Medical had 32,100 shareholders, an increase of 15.06% from the previous period. The average circulating shares per person rose to 18,048 shares, up by 186.92% [2]. - The top shareholders include: - Huabao Zhongzheng Medical ETF (512170) - 6.5935 million shares, decreased by 841,200 shares - Hong Kong Central Clearing Limited - 4.8997 million shares, increased by 823,000 shares - E Fund Growth Enterprise Board ETF (159915) - 3.8804 million shares, decreased by 656,700 shares [3].

Core Viewpoint - The stock of Steady Medical has experienced fluctuations, with a current price of 40.09 CNY per share and a market capitalization of 23.346 billion CNY, reflecting a year-to-date decline of 3.12% [1] Company Overview - Steady Medical, established on August 24, 2000, and listed on September 17, 2020, is located in Longhua District, Shenzhen, Guangdong Province. The company specializes in the research, production, and sales of cotton products [1] - The main revenue sources include consumer products such as wet and dry cotton towels (19.87%), medical consumables like surgical room products (18.15%), and traditional wound care products (13.88%) [1] Financial Performance - For the period from January to September 2025, Steady Medical reported a revenue of 7.897 billion CNY, marking a year-on-year growth of 30.10%. The net profit attributable to shareholders was 732 million CNY, reflecting a 32.36% increase compared to the previous year [2] - Since its A-share listing, the company has distributed a total of 2.875 billion CNY in dividends, with 1.729 billion CNY paid out in the last three years [3] Shareholder Information - As of September 30, 2025, the number of shareholders increased by 15.06% to 32,100, with an average of 18,048 shares held per shareholder, up by 186.92% [2] - The top shareholders include Huabao Zhongzheng Medical ETF, holding 6.5935 million shares, and Hong Kong Central Clearing Limited, holding 4.8997 million shares, with notable changes in their holdings compared to the previous period [3]

Core Viewpoint - The stock of Steady Medical has shown a positive trend recently, with a notable increase in trading volume and a significant rise in stock price over the past few weeks, indicating investor interest and confidence in the company's performance [1][2]. Company Overview - Steady Medical, established on August 24, 2000, and listed on September 17, 2020, is located in Longhua District, Shenzhen, Guangdong Province. The company specializes in the research, production, and sales of cotton products [1]. - The main revenue sources for Steady Medical include consumer products such as wet and dry cotton towels (19.87%), medical consumables like surgical room products (18.15%), and traditional wound care products (13.88%) [1]. Financial Performance - For the period from January to September 2025, Steady Medical reported a revenue of 7.897 billion yuan, reflecting a year-on-year growth of 30.10%. The net profit attributable to shareholders was 732 million yuan, marking a 32.36% increase compared to the previous year [2]. - Since its A-share listing, Steady Medical has distributed a total of 2.875 billion yuan in dividends, with 1.729 billion yuan paid out in the last three years [3]. Shareholder Information - As of September 30, 2025, the number of shareholders for Steady Medical reached 32,100, an increase of 15.06% from the previous period. The average number of circulating shares per person rose to 18,048, up by 186.92% [2]. - The top shareholders include Huabao Zhongzheng Medical ETF, holding 6.5935 million shares, and Hong Kong Central Clearing Limited, with 4.8997 million shares, showing changes in their holdings compared to the previous period [3].

Core Viewpoint - The financial report of Shengjian Medical for the first three quarters of 2025 shows significant growth in revenue and profit, indicating a strong performance in the healthcare and consumer goods sectors [1][2]. Financial Performance - The company's revenue for the first three quarters reached 7.897 billion yuan, a year-on-year increase of 30.10% [1]. - The net profit attributable to shareholders was 732 million yuan, up 32.36% year-on-year [1]. - The net profit excluding non-recurring items was 679 million yuan, reflecting a 43.93% increase year-on-year [1]. - Basic earnings per share stood at 1.26 yuan [1]. Profitability Metrics - The gross margin for the first three quarters was 48.32%, an increase of 0.18 percentage points year-on-year [2]. - The net profit margin was 9.81%, up 0.15 percentage points compared to the same period last year [2]. - In Q3 2025, the gross margin was 48.29%, showing a year-on-year increase of 1.29 percentage points [2]. - The net profit margin for Q3 was 9.87%, up 1.03 percentage points year-on-year [2]. Expense Analysis - Total operating expenses for Q3 amounted to 2.816 billion yuan, an increase of 586 million yuan year-on-year [2]. - The expense ratio was 35.66%, a decrease of 1.08 percentage points from the previous year [2]. - Sales expenses increased by 18.76%, management expenses rose by 40.12%, R&D expenses grew by 25.67%, and financial expenses surged by 95.52% year-on-year [2]. Shareholder Information - As of the end of Q3 2025, the total number of shareholders was 32,100, an increase of 4,203 or 15.06% from the end of the previous half [2]. - The average market value per shareholder decreased from 857,400 yuan to 694,400 yuan, a decline of 19.01% [2]. Company Overview - Shengjian Medical, established on August 24, 2000, and listed on September 17, 2020, is located in Longhua District, Shenzhen, Guangdong Province [3]. - The company specializes in the research, production, and sales of cotton products, with a revenue composition that includes various consumer and medical products [3]. - The company operates in the beauty and personal care sector, specifically in the life paper category, and is involved in multiple concept sectors including medical consumables and elderly care [3].

Company Overview - Steady Medical is located in Longhua District, Shenzhen, Guangdong Province, and was established on August 24, 2000. The company went public on September 17, 2020. Its main business involves the research, production, and sales of cotton products [1] - The company's revenue composition includes: consumer products - wet and dry cotton towels 19.87%, medical consumables - surgical room consumables 18.15%, medical consumables - traditional wound care and dressing products 13.88%, consumer products - sanitary napkins 13.02%, consumer products - adult clothing 12.73%, consumer products - baby clothing and supplies 11.36%, consumer products - other fiber products 5.24%, consumer products - other non-woven products 4.88%, and others 0.87% [1] Financial Performance - As of June 30, 2025, Steady Medical achieved operating revenue of 5.296 billion yuan, representing a year-on-year growth of 31.31%. The net profit attributable to the parent company was 492 million yuan, with a year-on-year increase of 28.07% [2] - Since its A-share listing, the company has distributed a total of 2.875 billion yuan in dividends, with 1.729 billion yuan distributed in the past three years [3] Shareholder Structure - As of June 30, 2025, the number of shareholders of Steady Medical was 27,900, an increase of 30.38% compared to the previous period. The average number of circulating shares per person was 6,290, a decrease of 23.30% [2] - The top circulating shareholder is Huabao Zhongzheng Medical ETF, holding 7.4347 million shares as a new shareholder. The second-largest shareholder is E Fund Growth Enterprise Board ETF, holding 4.5371 million shares, a decrease of 113,400 shares compared to the previous period [3]

Group 1 - The core viewpoint of the articles highlights the financial performance and market position of the company, Steady Medical, within the medical supplies industry [1][2] - As of July 4, the closing price of Steady Medical was 40.2 yuan, with a decline of 2.43%, resulting in a rolling PE ratio of 30.74 times and a total market capitalization of 23.41 billion yuan [1] - The average PE ratio for the beauty and healthcare industry is 38.96 times, with a median of 43.11 times, placing Steady Medical at the 13th position in the industry ranking [1][2] Group 2 - For the first quarter of 2025, the company reported a revenue of 2.605 billion yuan, representing a year-on-year increase of 36.47%, and a net profit of 249 million yuan, also reflecting a year-on-year growth of 36.26% [2] - The sales gross margin for the company stood at 48.46% [2] - The company specializes in the research, production, and sales of cotton-based products, including high-end wound dressings and various healthcare products, and has consistently ranked among the top three exporters of medical dressings in China [1]

Company Overview - Company name is稳健医疗, which focuses on the research, production, and sales of cotton-based products [1] - Main products include high-end wound dressings, traditional wound care and bandaging products, surgical consumables, infection protection products, health personal care products, cotton towels, cotton sanitary napkins, cotton wet wipes, non-woven consumer products, baby products, and adult clothing [1] - The company has consistently ranked among the top three in China's medical dressing exports for several years [1] Financial Performance - For Q1 2025, the company reported revenue of 2.605 billion yuan, a year-on-year increase of 36.47% [2] - Net profit for the same period was 249 million yuan, also reflecting a year-on-year growth of 36.26% [2] - The sales gross margin stood at 48.46% [2] Market Position - The company's current rolling price-to-earnings (PE) ratio is 30.45, while the average PE ratio for the beauty and personal care industry is 39.12 [1][2] - The industry median PE ratio is 42.46, placing the company at 13th in the industry ranking [1] - The total market capitalization of the company is 23.188 billion yuan [1] Capital Flow - On June 26, the company experienced a net outflow of main funds amounting to 2.0955 million yuan, with a total outflow of 24.8019 million yuan over the past five days [1]

Company Overview - Company name is稳健医疗, which closed at 50.47 yuan on June 10, with a 2.25% increase, resulting in a rolling PE ratio of 38.59 times and a total market value of 29.39 billion yuan [1] - The main business of the company includes research, production, and sales of cotton-based products, with key products being high-end wound dressings, traditional wound care products, surgical consumables, infection protection products, and personal health products [1] Financial Performance - For Q1 2025, the company reported revenue of 2.605 billion yuan, a year-on-year increase of 36.47%, and a net profit of 249 million yuan, also up 36.26%, with a gross profit margin of 48.46% [2] - The company's PE ratio is 38.59 (TTM) and 42.26 (static), with a price-to-book ratio of 2.58 [2] Industry Comparison - The average PE ratio for the beauty and personal care industry is 44.04, with a median of 49.17, placing the company at 14th in the industry ranking [1][2] - The total market value of the industry averages 115.99 billion yuan, with the median at 74.78 billion yuan [2] Market Position - The company has consistently ranked among the top three exporters of medical dressings in China for several years [1] - The "winner" brand has entered over 2,000 hospitals and nearly 40,000 pharmacies in China, with a significant presence in major chains [1]